Fukuda, K., Takeuchi, S., Arai, S., Kita, K., Tanimoto, A., Nishiyama, A., & Yano, S. (2020). Glycogen synthase kinase‐3 inhibition overcomes epithelial‐mesenchymal transition‐associated resistance to osimertinib in EGFR‐mutant lung cancer. Cancer Sci.
Čikaški stil citiranjaFukuda, Koji, Shinji Takeuchi, Sachiko Arai, Kenji Kita, Azusa Tanimoto, Akihiro Nishiyama, i Seiji Yano. "Glycogen Synthase Kinase‐3 Inhibition Overcomes Epithelial‐mesenchymal Transition‐associated Resistance to Osimertinib in EGFR‐mutant Lung Cancer." Cancer Sci 2020.
MLA način citiranjaFukuda, Koji, et al. "Glycogen Synthase Kinase‐3 Inhibition Overcomes Epithelial‐mesenchymal Transition‐associated Resistance to Osimertinib in EGFR‐mutant Lung Cancer." Cancer Sci 2020.